Dr Theresa Deisher: “Babies are Delivered Alive and Their Hearts Cut Out..

Dr Theresa Deisher, founder of Sound Choice Pharmaceutical Institute, speaks about her work in pioneering ethical alternatives to embryonic and foetal cell tissue research.
Theresa Deisher, Ph.D. (President, Sound Choice Pharmaceutical Institute , CEO and
Managing Member, AVM Biotechnology). Dr. Deisher, an expert in the field of adult
stem cell therapies and regenerative medicine, brings 18 years of experience in
scientific and corporate leadership positions involving research, discovery, production
and commercialization of human therapeutics. Dr. Deisher’s penchant for
groundbreaking scientific discovery and her distinguished scientific research has
resulted in 23 patents issued in her name. She has published numerous scientific
manuscripts and is a frequent invited lecturer and guest speaker in the area of stem cell
technology and regenerative medicine. Throughout her career, Dr. Deisher has been
recruited by some of the country’s top biotechnology companies, including
Genentech, Repligen, ZymoGenetics, Immunex and Amgen. She has managed and
mentored undergraduate honors students, post-doctoral fellows, scientific executives
and over 20 research assistants/scientists at all levels of responsibility.
Dr. Deisher graduated with honors and distinction from Stanford University, and
obtained her Ph.D. in Molecular and Cellular Physiology from the Department of
Molecular and Cellular Physiology, Stanford University.
Subsequent to obtaining her Ph.D from Stanford, Dr. Deisher was recruited by Repligen
Corporation (Cambridge, MA) and accepted a position as Research Scientist where
she managed a staff of associates and scientists and directed the development of
research and clinical assays in support of Phase I and Phase II clinical trials for various
Repligen developmental efforts. Additionally, Dr. Deisher was selected by Sr.
Management to participate in strategic alliance initiatives, including serving on the
Repligen / Eily Lilly joint development committee.